https://www.selleckchem.com/pr....oducts/epoxomicin-bu
The aims of this study were to evaluate the impact of body mass index (BMI) on the risk of reoperation for pelvic organ prolapse (POP) up to 5years after first-time surgery. This nationwide register-based study includes first-time POP surgery in 2010 through 2016. The cumulative incidence proportions of reoperation were analyzed in a Cox regression model and described using Kaplan-Meier plots stratified in BMI categories. A total of 28,533 first-time procedures were performed in 22,624 women; 76.6% had single-compartment rep